Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion

Cancer

Volumn 91, Issue 3, 2001, Pages 496-504

  Sato, Norihiro ^a   Maehara, Naoki ^b   Mizumoto, Kazuhiro ^a   Nagai, Eishi ^a   Yasoshima, Takahiro ^b   Hirata, Koichi ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell motility; Cell proliferation; Invasion; Pancreatic carcinoma; Telomerase

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; TELOMERASE; TELOMERASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DISEASE MARKER; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

CELL DIVISION; CELL MOVEMENT; HUMANS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035253472     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010201)91:3<496::AID-CNCR1028>3.0.CO;2-0     Document Type: Article

References (59)

1. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
2. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats
3. Telomerase, cell immortality, and cancer
4. Specific association of human telomerase activity with immortal cells and cancer
5. A survey of telomerase activity in human cancer
6. Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms
7. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis
8. Telomerase activity in human solid tumors. Diagnostic utility and clinical applications
9. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis
10. Anti-apoptotic role of telomerase in pheochromocytoma cells
11. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability
12. Telomerase activity: A biomarker of cell proliferation, not malignant transformation
13. Role of telomerase in cellular proliferation and cancer
14. Telomerase activity, cell proliferation, and cancer
15. Analysis of telomerase activity levels in breast cancer: Positive detection at the in situ breast carcinoma stage
16. Correlation between telomerase activity and DNA ploidy in gastric cancer
17. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor
18. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro
19. Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide
20. Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: In vitro studies with fresh human tumor samples
21. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer
22. Correlating telomerase activity levels with human neuroblastoma outcomes
23. Telomerase activity in neuroblastoma: Is it a prognostic indicator of clinical behaviour?
24. Telomerase activity in gastric cancer
25. Telomerase activity and survival of patients with node-positive breast cancer
26. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer
27. Prognostic impact of telomerase activity in non-small cell lung cancers
28. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia
29. Telomerase activity in ordinary meningiomas predicts poor outcome
30. Establishment and characterization of new cell lines derived from human pancreatic cancers
31. Establishment and characterization of human pancreatic carcinoma lines with a high metastatic potential in the liver of nude mice
32. The RNA component of human telomerase
33. Alterations of the p53 tumor suppressor gene and Ki-ras oncogene in human pancreatic cancer-derived cell lines with different metastatic potential
34. Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse
35. Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential
36. A cystic fibrosis pancreatic adenocarcinoma cell line
37. Characterization of a new primary human pancreatic tumor line
38. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9
39. Numerical aberrations of chromosomes 1 and 17 in tumor cell lines of the exocrine pancreas as determined by fluorescence in situ hybridization
40. Establishment of quantitative reverse transcription-polymerase chain reaction assays for human telomerase-associated genes
41. Molecular aspects of the metastatic cascade
42. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states
43. Telomerase activity is detected in pancreatic cancer but not in benign tumors
44. Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia
45. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation
46. Apoptosis and metastasis: A superior resistance of metastatic cancer cells to programmed cell death
47. A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma
48. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA
49. NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA
50. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA
51. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine
52. FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis
53. Inhibition of human telomerase activity by peptide nucleic acids
54. Inhibition of human telomerase by 2′-O-methyl-RNA
55. 9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells
56. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines
57. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells
58. Inhibition of telomerase limits the growth of human cancer cells
59. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells